cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

Fri, Aug 21

Perspectives

cbdMD reported Q3 FY2026 results with 20% year-over-year revenue growth, wholesale net sales up 61%, continued Oasis beverage momentum, and a full quarter of Bluebird Botanicals contribution. As regulation evolves, cbdMD is focused on quality, compliance, safety data, trusted

359

Accelerating Oasis Beverage Momentum, a Full Quarter of Bluebird Botanical Contribution, and Advancing Federal Hemp Legislation Strengthen the Company's Positioning for Competing under Pending...

Discover